Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Triptan use in general practice: a French pharmacoepidemiological study].

Jean-Michel Sénard1, Fatima Nachit-Ouinekh, Jean-Philippe Becq

  • 1Service de Pharmacologie Clinique, INSERM U586, Toulouse, France.

Therapie
|January 15, 2005
PubMed
Summary

This study on triptan use in general practice found that migraines in treated patients were more severe. Non-naive patients, previously treated with triptans, reported longer histories and worse quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodology of DNA extraction and sequencing from living cardiomyocytes collected by catheter in humans.

Genetics in medicine open·2026
Same author

Delaying disease progression in COPD with early escalation to triple therapy: a modelling study (DEPICT-2).

ERJ open research·2025
Same author

Unveiling the native architecture of adult cardiac tissue using the 3D-NaissI method.

Cellular and molecular life sciences : CMLS·2025
Same author

Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries.

Infectious disease reports·2024
Same author

Understanding the Gaps in the Reporting of COPD Exacerbations by Patients: A Review.

COPD·2024
Same author

Cerebrovascular and cardiovascular autonomic regulation in sickle cell patients with white matter lesions.

European journal of neurology·2024

Area of Science:

  • Pharmacoepidemiology
  • Neurology
  • Clinical Pharmacy

Context:

  • Triptan therapy is crucial for migraine management.
  • General practitioners play a key role in prescribing triptans.
  • Understanding patient profiles (naive vs. non-naive) is essential for optimizing treatment.

Purpose:

  • To describe triptan utilization in French general practice.
  • To compare triptan use in patients new to therapy versus those previously treated.
  • To analyze patient characteristics and reasons for treatment changes.

Summary:

  • A pharmacoepidemiological study analyzed 1774 patients (81% female, mean age 41) diagnosed with migraine per International Headache Society (IHS) criteria.
  • Patients receiving triptans exhibited more severe migraines than the general migraine population.

Related Experiment Videos

  • 'Naive' and 'non-naive' patients had similar IHS diagnoses, but 'non-naive' patients had longer migraine histories and greater disability.

    • Impact:

    • Confirms effective triptan use by general practitioners.
    • Highlights the need for improved efficacy, faster onset, reduced recurrence, and better tolerability in migraine treatment.
    • Provides insights into patient-reported outcomes influencing treatment switches.